AbbVie Inc.’s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs ...

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Investing some of your tax refund in stocks can help build your portfolio. The three stocks below trade at forward earnings ...

Immunology Drugs Drive ABBV’s Top Line In immunology, net revenues from Rinvoq for the fourth quarter totaled $1.83 billion, up 47.1%. The upside can be attributed to label expansions of the ...

MoonLake, a clinical-stage biopharma company developing immunology therapeutics, was created by an April 2022 merger with ...

By Distribution Channel, Hospital pharmacies captured the largest market share in 2023, remaining the primary distribution channel for immunology drugs. Hospitals are equipped with specialty care ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

"The collaboration with BridGene underscores our commitment to pioneering advancements in neurology and immunology to transform ... pipeline of first-in-class drugs for targets in multiple disease ...

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss market. Brands such as Wegovy and Zepbound -- the leading anti-obesity ...

Its immunology franchise sales reached about $ ... These next-generation drugs often have competitive advantages in efficacy and safety profiles relative to those being developed by competitors ...